Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 16Advanced Solid Tumors 6Advanced Solid Tumor 5Solid Tumors 4Solid Tumor 4Mesothelioma 3Unspecified Childhood Solid Tumor, Protocol Specific 1Resectable Colon Cancer 1Relapsed Solid Tumor 1Pseudomyxoma Peritonei 1Peritoneal Neoplasms 1Patients With Advanced or Metastatic Solid Tumors 1Mesothelioma, Malignant 1Malignant Solid Tumour 1MSI-H Colorectal Cancer 1Locally Advanced and Metastatic Solid Tumors 1HER2-positive 1DMMR Colorectal Cancer 1Childhood Central Nervous System Choriocarcinoma 1Advanced Solid Tumour 1Advanced Solid Tumor Cancer 1

Interventions

Cisplatin 57Pemetrexed 46pembrolizumab 18Nivolumab 15Carboplatin 15Gemcitabine 14Cyclophosphamide 13Radiotherapy 10Drug Therapy 9atezolizumab 8Platinum 7Ipilimumab 7Doxorubicin 7durvalumab 61,2-diaminocyclohexaneplatinum II citrate 6tremelimumab 5sodium thiosulfate 5Vinorelbine 5Radiotherapy, Intensity-Modulated 5Interleukin-2 5Chemotherapy, Adjuvant 5Cerebral Decortication 5sargramostim 4fludarabine 4defactinib 4aldesleukin 4tumor necrosis factor-alpha, CNGRC fusion protein, human 3cediranib 3Photochemotherapy 3Neoadjuvant Therapy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mesothelioma, Malignant × Oxaliplatin × Other solid neoplasm × Clear all
NCT00996385 2011-10-31

Velcade and Eloxatin for Patients With Malignant Pleural or Peritoneal Mesothelioma

Columbia University

Phase 2 Unknown
29 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡